Kanabo Group (LSE:KNB), a health-tech company focused on patient care with its innovative digital healthcare platform and medical cannabis treatment portfolio, announced Ian Mattioli's appointment as chair of the board.
The £2.5 million ($3.15 million) minimum investment round includes an institutional investor, company management, and Ian Mattioli's £500,000 investment. This funding will support Kanabo's UK market expansion, further developing its telehealth offering, and accelerating the integration of additional treatments into its digital health platform and medical cannabis product line.
David Tsur, Kanabo's outgoing chair, welcomed Mattioli to the leadership team, stating:
"We are pleased to …